Basic information |
Metabolite name | Carbamoyl phosphate |
HMDB0001096 | |
C00169 | |
278 | |
Synonyms | NA |
No. of studies | 8 |
Relationship between Carbamoyl phosphate and depression (count: 8) |
Study | Study Type | Comparison groups | Tissue | Organism | Up/Down regulated |
Study M033 | Type3 | paroxetine group vs. control group | Hippocampus | DBA/2OlaHsd mouse | Down |
Study M050 | Type3 | 24h Ketamine group vs. control group | Hippocampus | C57BL/6 mouse | Down |
Study M086 | Type5 | paroxetine-treated responder group vs. non-responder group | Hippocampus | DBA/2J mouse | Up |
Study M112 | Type5 | paroxetine-treated responder group vs. non-responder group | Prefrontal cortex | DBA/2J mouse | Up |
Study M112 | Type5 | paroxetine-treated responder group vs. non-responder group | Hippocampus | DBA/2J mouse | Up |
Study M592 | Type1 | CUMS group vs. control group, LC-MS | Liver | Sprague-Dawley rat | Down |
Study M593 | Type1 | CUMS group vs. control group | Liver | Sprague-Dawley rat | Down |
Study M593 | Type2 | CUMS + low dose of Radix Bupleuri-Radix Paeoniae Alba herb pair group vs. CUMS group | Liver | Sprague-Dawley rat | Up |
Study M593 | Type2 | CUMS + high dose of Radix Bupleuri-Radix Paeoniae Alba herb pair group vs. CUMS group | Liver | Sprague-Dawley rat | Up |
Study M593 | Type2 | CUMS + venlafaxine group vs. CUMS group | Liver | Sprague-Dawley rat | Up |
Study M858 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Down |
Study M911 | Type1 | CUS group vs. control group | Serum | Sprague-Dawley rat | Up |